Cite
Immune-Checkpoint Blockade Enhances 225 Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer.
MLA
Czernin, Johannes, et al. “Immune-Checkpoint Blockade Enhances 225 Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 62, no. 2, Feb. 2021, pp. 228–31. EBSCOhost, https://doi.org/10.2967/jnumed.120.246041.
APA
Czernin, J., Current, K., Mona, C. E., Nyiranshuti, L., Hikmat, F., Radu, C. G., & Lückerath, K. (2021). Immune-Checkpoint Blockade Enhances 225 Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 62(2), 228–231. https://doi.org/10.2967/jnumed.120.246041
Chicago
Czernin, Johannes, Kyle Current, Christine E Mona, Lea Nyiranshuti, Firas Hikmat, Caius G Radu, and Katharina Lückerath. 2021. “Immune-Checkpoint Blockade Enhances 225 Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 62 (2): 228–31. doi:10.2967/jnumed.120.246041.